A Survey of Canadian Practitioners Regarding the Management of the Hypertensive Disorders of Pregnancy

Abstract

This survey has clarified current stated management of women with HDP, and identified the need for both research into the dBP treatment goal that optimizes pregnancy outcomes among women with HDP, and translation of definitive studies into clinical practice.

Women's Views of Their Experiences in the CHIPS (Control of Hypertension in Pregnancy Study) Pilot Trial

“…Women's views could have been directly influenced by their physician's views. However, our survey of Canadian physicians indicated that Canadian obstetricians are divided on the optimal dBP goal for non-proteinuric hypertension in pregnancy, and that the majority of clinicians would not favor dBP <90 mm Hg (14). The basis of women's views needs to be further explored in the main CHIPS Trial, and the lack of adequate evidence identifying the dBP goal that optimizes perinatal and maternal outcomes must continue to be emphasized.…”

Effects of Guided Imagery on Blood Pressure in Pregnant Women with Hypertension: A Pilot Randomized Controlled Trial

“…Neither study site had specific clinical criteria in place for treatment of mild to moderate hypertension; clinicians made their own judgments with respect to clinical management. Results from a survey of Canadian physicians providing care to pregnant women suggested that clinical decisions about if and when to initiate pharmacological or other treatment for hypertension in pregnancy varied widely (31).…”

RETIRED: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

“…Labetalol and methyldopa are the oral agents used most frequently in Canada [350] (Table 7). ACE inhibitors and ARBs are fetotoxic [351] (particularly nephrotoxic) [352].…”